1. Home
  2. ONCO vs UGRO Comparison

ONCO vs UGRO Comparison

Compare ONCO & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Onconetix Inc.

ONCO

Onconetix Inc.

HOLD

Current Price

$0.83

Market Cap

2.3M

Sector

Health Care

ML Signal

HOLD

Logo urban-gro Inc.

UGRO

urban-gro Inc.

SELL

Current Price

$3.67

Market Cap

2.5M

ML Signal

SELL

Company Overview

Basic Information
Metric
ONCO
UGRO
Founded
2018
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.3M
2.5M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
ONCO
UGRO
Price
$0.83
$3.67
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$75.00
AVG Volume (30 Days)
480.1K
48.3K
Earning Date
11-13-2025
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,223,751.00
$23,942,741.00
Revenue This Year
N/A
$98.41
Revenue Next Year
N/A
$23.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$2.84
52 Week High
$47.66
$21.50

Technical Indicators

Market Signals
Indicator
ONCO
UGRO
Relative Strength Index (RSI) 38.02 87.29
Support Level $1.15 $0.11
Resistance Level $1.86 $4.50
Average True Range (ATR) 0.18 0.21
MACD -0.01 0.38
Stochastic Oscillator 2.81 74.24

Price Performance

Historical Comparison
ONCO
UGRO

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

Share on Social Networks: